Feasibility of CycleGAN enhanced low dose CBCT imaging for prostate radiotherapy dose calculation
Yan Chi Ivy Chan,Minglun Li,Katia Parodi,Claus Belka,Guillaume Landry,Christopher Kurz
DOI: https://doi.org/10.1088/1361-6560/acccce
IF: 3.5
2023-04-14
Physics in Medicine and Biology
Abstract:Objective: Daily CBCT imaging during the course of fractionated radiotherapy treatment can enable online adaptive radiotherapy but also expose patients to a non-negligible amount of radiation dose. This work investigates the feasibility of low dose CBCT imaging capable of enabling accurate prostate radiotherapy dose calculation with only 25% projections by overcoming under-sampling artifacts and correcting CT numbers by employing cycle-consistent generative adversarial networks (cycleGAN).
Approach: Uncorrected CBCTs of 41 prostate cancer patients, acquired with ∼350 projections (CBCT org ), were retrospectively under-sampled to 25% dose images (CBCT LD ) with only ∼90 projections and reconstructed using FDK. We adapted a cycleGAN including shape loss to translate CBCT LD into planning CT (pCT) equivalent images (CBCT LD_GAN ). An alternative cycleGAN with a generator residual connection was implemented to improve anatomical fidelity (CBCT LD_ResGAN ).
Unpaired 4-fold cross-validation (33 patients) was performed to allow using the median of 4 models as output. Deformable image registration was used to generate virtual CTs (vCT) for Hounsfield units (HU) accuracy evaluation on 8 additional test patients. Volumetric modulated arc therapy (VMAT) plans were optimized on vCT, and recalculated on CBCT LD_GAN and CBCT LD_ResGAN to determine dose calculation accuracy. CBCT LD_GAN , CBCT LD_ResGAN and CBCT org were registered to pCT and residual shifts were analyzed. Bladder and rectum were manually contoured on CBCT LD_GAN , CBCT LD_ResGAN and CBCT org and compared in terms of dice similarity coefficient (DSC), average and 95th percentile Hausdorff distance (HD avg , HD 95 ).
Main results: The mean absolute error decreased from 126 HU for CBCT LD to 55 HU for CBCT LD_GAN and 44 HU for CBCT LD_ResGAN . For PTV, the median differences of D 98% , D 50% and D 2% comparing CBCT LD_GAN to vCT were 0.3%, 0.3% and 0.3%, and comparing CBCT LD_ResGAN to vCT were 0.4%, 0.3% and 0.4%. Dose accuracy was high with both 2% dose difference pass rates of 99% (10% dose threshold). Compared to CBCT org -to-pCT registration, the majority of mean absolute differences of rigid transformation parameters were less than 0.20 mm/ 0.20°. For bladder and rectum, the DSC were 0.88 and 0.77 for CBCT LD_GAN and 0.92 and 0.87 for CBCT LD_ResGAN compared to CBCT org , and HD avg were 1.34 mm and 1.93 mm for CBCT LD_GAN , and 0.90 mm and 1.05 mm for CBCT LD_ResGAN . The computational time was ∼2 s per patient.
Significance: This study investigated the feasibility of adapting two cycleGAN models to simultaneously remove under-sampling artifacts and correct image intensities of 25% dose CBCT images. High accuracy on dose calculation, HU and patient alignment were achieved. CBCT LD_ResGAN achieved better anatomical fidelity.
engineering, biomedical,radiology, nuclear medicine & medical imaging